Core Scientific, Inc. Common Stock (CORZ) — Capital Reinvestment Ratio
Core Scientific, Inc. Common Stock (CORZ) has a Capital Reinvestment Ratio of 1.56x as of March 2026, meaning it reinvests 2% of its operating cash flow ($249.88 Million) in capital expenditures ($389.23 Million). Check Core Scientific, Inc. Common Stock (CORZ) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Core Scientific, Inc. Common Stock Capital Reinvestment Ratio (2022–2025)
This chart tracks Core Scientific, Inc. Common Stock's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see CORZ cash flow conversion.
Annual Capital Reinvestment Ratio for Core Scientific, Inc. Common Stock (2022–2025)
Year-by-year Capital Reinvestment Ratio for Core Scientific, Inc. Common Stock from 2022 to 2025. See Core Scientific, Inc. Common Stock free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.62x | $278.25 Million | $729.00 Million | ▲ +18.3% |
| 2024 | 2.21x | $42.90 Million | $94.96 Million | ▲ +791.9% |
| 2023 | 0.25x | $65.11 Million | $16.16 Million | ▼ -91.5% |
| 2022 | 2.93x | $205.19 Million | $601.66 Million | — |